Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 1
2005 2
2006 3
2009 1
2010 3
2011 1
2012 1
2015 1
2016 2
2018 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Analgesic Effects of 5-Alkyloxy-4-amino-2(5H)-furanones as Cholecystokinin-2 Antagonists.
Lattmann E, Sattayasai J, Schwalbe CH, Boonprakob Y, Dunn S, Fajana F, Lattmann P. Lattmann E, et al. Arch Pharm (Weinheim). 2016 Jun;349(6):456-65. doi: 10.1002/ardp.201600036. Epub 2016 May 3. Arch Pharm (Weinheim). 2016. PMID: 27142294
Microscopy imaging of liposomes: from coverslips to environmental SEM.
Bibi S, Kaur R, Henriksen-Lacey M, McNeil SE, Wilkhu J, Lattmann E, Christensen D, Mohammed AR, Perrie Y. Bibi S, et al. Among authors: lattmann e. Int J Pharm. 2011 Sep 30;417(1-2):138-50. doi: 10.1016/j.ijpharm.2010.12.021. Epub 2010 Dec 21. Int J Pharm. 2011. PMID: 21182914 Review.
Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.
Wilkinson A, Lattmann E, Roces CB, Pedersen GK, Christensen D, Perrie Y. Wilkinson A, et al. Among authors: lattmann e. J Control Release. 2018 Dec 10;291:1-10. doi: 10.1016/j.jconrel.2018.10.002. Epub 2018 Oct 3. J Control Release. 2018. PMID: 30291987 Free article.
Anticancer Effects of Curcuma C20-Dialdehyde against Colon and Cervical Cancer Cell Lines.
Chaithongyot S, Asgar A, Senawong G, Yowapuy A, Lattmann E, Sattayasai N, Senawong T. Chaithongyot S, et al. Among authors: lattmann e. Asian Pac J Cancer Prev. 2015;16(15):6513-9. doi: 10.7314/apjcp.2015.16.15.6513. Asian Pac J Cancer Prev. 2015. PMID: 26434867 Free article.
Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists.
Lattmann E, Singh H, Boonprakob Y, Lattmann P, Sattayasai J. Lattmann E, et al. J Pharm Pharmacol. 2006 Mar;58(3):393-401. doi: 10.1211/jpp.58.3.0015. J Pharm Pharmacol. 2006. PMID: 16536908
Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.
Ponnusamy S, Lattmann E, Lattmann P, Thiyagarajan T, Padinjarethalakal BN, Narayanan R. Ponnusamy S, et al. Among authors: lattmann e. Oncol Rep. 2016 Apr;35(4):2097-106. doi: 10.3892/or.2016.4588. Epub 2016 Jan 22. Oncol Rep. 2016. PMID: 26820391
Antipyretic, analgesic and anti-oxidative activities of Aquilaria crassna leaves extract in rodents.
Sattayasai J, Bantadkit J, Aromdee C, Lattmann E, Airarat W. Sattayasai J, et al. Among authors: lattmann e. J Ayurveda Integr Med. 2012 Oct;3(4):175-9. doi: 10.4103/0975-9476.104427. J Ayurveda Integr Med. 2012. PMID: 23326086 Free PMC article.
In-vitro and in-vivo antivenin activity of 2-[2-(5,5,8a-trimethyl-2-methylene-decahydro-naphthalen-1-yl)-ethylidene]-succinaldehyde against Ophiophagus hannah venom.
Lattmann E, Sattayasai J, Sattayasai N, Staaf A, Phimmasone S, Schwalbe CH, Chaveerach A. Lattmann E, et al. J Pharm Pharmacol. 2010 Feb;62(2):257-62. doi: 10.1211/jpp.62.02.0014. J Pharm Pharmacol. 2010. PMID: 20487206
In vivo evaluation of substituted 3-amino-1,4-benzodiazepines as anti-depressant, anxiolytic and anti-nociceptive agents.
Lattmann E, Lattmann P, Boonprakob Y, Airarat W, Singh H, Offel M, Sattayasai J. Lattmann E, et al. Arzneimittelforschung. 2009;59(2):61-71. doi: 10.1055/s-0031-1296366. Arzneimittelforschung. 2009. PMID: 19338136
Synthesis and evaluation of N1-substituted-3-propyl-1,4-benzodiazepine-2-ones as cholecystokinin (CCK2) receptor ligands.
Lattmann E, Sattayasai J, Billington DC, Poyner DR, Puapairoj P, Tiamkao S, Airarat W, Singh H, Offel M. Lattmann E, et al. J Pharm Pharmacol. 2002 Jun;54(6):827-34. doi: 10.1211/0022357021779005. J Pharm Pharmacol. 2002. PMID: 12078999
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback